HAVCR2 and cancer: In DC subsets, cDC1 were associated with improved overall survival in cancer patients 63, and it has been shown that the expression of cDC2 gene signatures correlated with positive prognoses 64, while cDC2 with high expression of Tim-3, however, predicted poor survival, indicating Tim-3+cDC2 is an immune-suppressive cell population.